Showing 1 - 6 results of 6 for search 'Comstock TL', query time: 0.02s Refine Results
  1. 1
    An update on the surgical management of pterygium and the role of loteprednol etabonate ointment

    An update on the surgical management of pterygium and the role of loteprednol etabonate ointment by Sheppard JD, Mansur A, Comstock TL, Hovanesian JA

    Published 2014-06-01
    Get full text
    Article
  2. 2
    Clinical outcomes with besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis due to potentially consequential pathogens

    Clinical outcomes with besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis due to potentially consequential pathogens by Comstock TL, Morris TW, Gearinger LS, DeCory HH

    Published 2014-04-01
    Get full text
    Article
  3. 3
    Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections

    Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections by Silverstein BE, Morris TW, Gearinger LS, DeCory HH, Comstock TL

    Published 2012-11-01
    Get full text
    Article
  4. 4
    Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant

    Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant by Sheppard Jr JD, Nguyen QD, Usner DW, Comstock TL; Fluocinolone Acetonide Uveitis Study Group

    Published 2012-01-01
    Get full text
    Article
  5. 5
    Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes

    Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes by Morris TW, Gearinger LS, Usner DW, Paterno MR, DeCory HH, Comstock TL, Haas W

    Published 2011-09-01
    Get full text
    Article
  6. 6
    Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery

    Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery by Bucci FA Jr, Evans RE, Amico LM, Morris TW, Fluet AT, Sanfilippo CM, DeCory HH, Comstock TL

    Published 2015-05-01
    Get full text
    Article

Search Tools: